When manufacturing the secondary packaging of these combination devices, all the components must be produced at the same quality level and possess verifiable compliance to the most stringent quality standards even when production is running 24/7. Therefore, it is paramount that SHL chooses the right machine partner, and KraussMaffei has proven over the years that they are the right quality choice.
"With the CX series of machines, we have further enhanced reliability and continue to consistently produce high-quality components for the medical and healthcare industry worldwide. Our goal is zero error tolerance, a goal that our partners must share with us. KraussMaffei is a preferred while excellent partner for us", comments Roger Samuelsson, CEO & President of SHL Group.
SHL continues to manufacture high quality medical devices for customers by providing a suite of integrated solutions which includes design, development, manufacturing capabilities and final assembly all in-house. By doing so, SHL can supervise each key development and manufacturing stages to ensure quality and compliance and involve and update the customers when appropriate.
As the world’s biopharmaceutical companies’ demands for combination products like auto injectors and pen injectors continues to grow, SHL will also substantiate relationships with quality partners like KraussMaffei to provide the highest quality services and manufacturing capabilities to customers.